Clinical research for inserting levonorgestrel-releasing intrauterine system (LNG-IUS) in Laparoscopic myomectomy(LM)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025279

Enrollment

Unknown

Registered

2019-08-20

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hysteromyoma

Interventions

Case series:inserting LNG-IUS in Laparoscopic myomectomy.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients who inserting levonorgestrel-releasing intrauterine system (LNG-IUS) in Laparoscopic myomectomy(LM) in our hospital 2. Patients with follow-up conditions after surgery 3. Be voluntory to this trial and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Heart, liver, lung and other organ dysfunction, surgical contraindication; 2. Be allergic to or contraindicated to LNG-IUS; 3. Contraindications included pregnancy with accute genital tract inflamation or gynecological malignant diseases such as ovarian cancer; 4. Uterine cavity length longer than 9 cm.

Design outcomes

Primary

Measure	Time frame
Menstrual pattern;Contracepti;the size of uterine fibroids;	—

Countries

China

Contacts

Public ContactLi Yang

The Third Affiliated Hospital of Zhengzhou University

zdsfyyangli@163.com+86 18697336662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026